Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T19:10:31.043Z.
Consensus retrieved: unavailable. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T19:10:31.043Z.
Quote observation: 2026-10-06T19:00:48.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 8d554412806125b06490580232e6d80b3120c6a72214b764814008bb1d876b03
FORWARD PE RATIO
N/A
Ainos, Inc.
Market Cap
$9.65M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Ainos, Inc. (AIMD) | $9.65M | N/A |
| NeuroOne Medical Technologies Corporation (NMTC)vs › | $9.66M | N/A |
| Valion Bio, Inc. (VBIO)vs › | $9.82M | N/A |
| MetaVia Inc. (MTVA)vs › | $9.88M | N/A |
| Advanced Biomed Inc. Common Stock (ADVB)vs › | $9.24M | N/A |
| Lifeward Ltd. (LFWD)vs › | $10.10M | N/A |
| Medicus Pharma Ltd. Common Stock (MDCX)vs › | $10.10M | N/A |
| Tvardi Therapeutics, Inc. (TVRD)vs › | $10.18M | N/A |
| SeaStar Medical Holding Corporation (ICU)vs › | $9.10M | N/A |
| Senti Biosciences, Inc. (SNTI)vs › | $10.30M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus fiscal-year EPS
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
